Clinical experience with cabergoline, a new ergoline derivative, in the treatment of Parkinson's disease.

Jori, M C

Clinical experience with cabergoline, a new ergoline derivative, in the treatment of Parkinson's disease. [electronic resource] - Advances in neurology 1990 - 539-43 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study

0091-3952


Administration, Oral
Aged
Antiparkinson Agents
Cabergoline
Dose-Response Relationship, Drug
Drug Administration Schedule
Ergolines--administration & dosage
Female
Humans
Male
Neurologic Examination
Parkinson Disease--drug therapy